[1] GSK presents promising new data for bepirovirsen, an investigational treatment for chronic hepatitis B, Retrieved June 27, 2022, from https://www.gsk.com/en-gb/media/press-releases/gsk-presents-promising-new-data-for-bepirovirsen-an-investigational-treatment-for-chronic-hepatitis-b/
[2] GSK says its drug for chronic hep B could ‘lead to a functional cure’ — but will it be alone or in combination? Retrieved June 27, 2022, from https://endpts.com/gsk-says-its-drug-for-chronic-hep-b-could-lead-to-a-functional-cure-but-will-it-be-alone-or-in-combination/
[3] GSK stakes out path to hepatitis B functional cure after clearing virus in phase 2b trial, Retrieved June 27, 2022, from https://www.fiercebiotech.com/biotech/gsk-stakes-out-path-hepatitis-b-functional-cure-after-clearing-virus-phase-2b-trial
[4] GSK, Ionis Present "Potentially Transformative" Data from Hepatitis B Hopeful, Retrieved June 27, 2022, from https://www.biospace.com/article/gsk-ionis-partnership-poised-to-transform-hep-b-space-with-promising-phase-2-data/